| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Country's Decision or any other Communication
Record information and status
Record ID
113494
Status
Published
Date of creation
2016-06-24 14:28 UTC (gutemberg.sousa@mctic.gov.br)
Date of publication
2018-06-15 13:36 UTC (dema@itamaraty.gov.br)

General information
Country submitting the decision or communication
  • Brazil
Competent National Authority(ies) responsible for the decision or communication
National Technical Biosafety Commission
Setor Policial Sul -SPO Área 5 Quadra 3 Bloco B - Térreo Salas 10 à 14
Brasília, DF
Brazil, CEP - 70610-200
Phone:(5561) 3411-5516
Fax:(5561) 3317-7475
Email:ctnbio@mct.gov.br
Url:National Technical Biosafety Comission
Title / Reference number of the decision or communication
Commercial Release of Bovela® Modified Live Vaccine against Type 1 and Type 2 Bovine Diarrhea Virus
Date of the decision
2015-06-10
Is the decision taken prior to entry into force of the Protocol?
No
Is this an amendment to a previous decision / communication?
No
Decision or communication details
Subject(s) of the decision
  • Decision on Pharmaceuticals (Article 5)
LMO identification
Bovela® Vaccine
Dra Patrícia Schwarz Production of medical or pharmaceutical compounds (human or animal) - Vaccines
Risk assessment
Risk Assessment Bovela® Modified Live Vaccine against Type 1 and Type 2 Bovine Diarrhea Virus
Bovela® Vaccine
Dra Patrícia Schwarz

Production of medical or pharmaceutical compounds (human or animal) - Vaccines
Decision document
Decision document